ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 75 filers reported holding ALBIREO PHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $533,000 | -28.1% | 22,889 | -3.7% | 0.00% | -33.3% |
| Q3 2021 | $741,000 | -4.6% | 23,757 | +7.6% | 0.00% | 0.0% |
| Q2 2021 | $777,000 | -18.6% | 22,084 | -18.4% | 0.00% | -25.0% |
| Q1 2021 | $954,000 | -5.9% | 27,063 | +0.1% | 0.00% | 0.0% |
| Q4 2020 | $1,014,000 | +66.0% | 27,028 | +47.7% | 0.00% | +100.0% |
| Q3 2020 | $611,000 | +32.3% | 18,303 | +5.0% | 0.00% | 0.0% |
| Q2 2020 | $462,000 | -80.7% | 17,438 | -81.5% | 0.00% | -75.0% |
| Q4 2019 | $2,394,000 | -37.9% | 94,187 | -51.2% | 0.01% | -42.9% |
| Q3 2019 | $3,857,000 | -36.9% | 192,850 | +1.8% | 0.01% | -36.4% |
| Q2 2019 | $6,109,000 | +771.5% | 189,500 | +770.4% | 0.02% | +633.3% |
| Q1 2019 | $701,000 | – | 21,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |